Benzinga·Mar 4·Globe NewswireBioCryst Grants 65,850 RSUs to New Hires Under Nasdaq Inducement RuleBioCryst awards 65,850 RSUs to six new employees under Nasdaq inducement rule, vesting over four years starting March 2027. BCRXrestricted stock unitsbiotechnology
GlobeNewswire Inc.·Feb 26·NaBioCryst Achieves Historic Profitability as ORLADEYO Revenue Surges 38%BioCryst achieved historic profitability with ORLADEYO revenue surging 38% to $601.8 million. FDA approval for pediatric formulation and Astria acquisition expand HAE treatment portfolio. BCRXFDA approvalprofitability